Brett Staahl

Brett Staahl

Company: Scribe Therapeutics

Job title: Co-Founder & Head of Platform Technologies


Advancing CRISPR-based Genetic Medicine for Highly Efficient and Specific Genome Modification 2:30 pm

• Pioneering novel viral and non-viral delivery technologies to truly enable in vivo genetic medicine • Outlining X-editing (XE) technology to provide greater activity, specificity and deliverability • Utilizing XE to address diseases of significant unmet medical needRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.